2192 — Medlive Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$5.44bn
- HK$690.68m
- CNY314.05m
- 62
- 41
- 39
- 44
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 16 | 37 | 105 | 69.9 | 135 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.654 | 1.02 | -1.75 | 15.7 | 17.3 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.06 | -14.6 | 2.63 | -47.3 | -84.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 22.1 | 28.2 | 111 | 44.4 | 77.2 |
Capital Expenditures | -3.1 | -2.43 | -0.626 | -1.97 | -7.49 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | 0.639 | -48.6 | -3,578 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.1 | -2.43 | 0.013 | -50.5 | -3,586 |
Financing Cash Flow Items | -2.79 | -0.296 | -0.209 | -0.535 | -5.24 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.85 | -3.43 | -2.83 | 3,792 | -22.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 13.2 | 22.4 | 108 | 3,732 | -3,201 |